Another Ghostly Apparition
The Halloween guest list continues to grow. As reported in the New York Times and highlighted by Jim Edwards in BNET Pharma, the FY 2004 marketing plan for Forest Labs’ antidepressant Lexapro included...
View ArticleClik here to view.
Zika Emergency Puts Open Data Policies to the Test
The Zika outbreak comes at a time of ongoing advances in data sharing policy, including a new call by the Wellcome Trust for journals and research funders to support open sharing of Zika research....
View ArticleClik here to view.
Expanding the Blue Marble Health Collection
PLOS Neglected Tropical Diseases co-Editor-in-Chief Peter J Hotez , Chief Editor of PLOS Medicine Larry Peiperl and Editorial Project Manager of PLOS Collections Nathaniel Gore on the latest update to...
View ArticleClik here to view.
UN World Toilet Day 2016
PLOS Medicine and PLOS NTDs reflect on 15 years of World Toilet Day and announce the WASH Collection. UN World Toilet Day highlights the urgent need to address a global sanitation crisis by providing...
View ArticleNew ICMJE Requirements and the PLOS Data Policy
PLOS Medicine Chief Editor Larry Peiperl discusses the PLOS data policy in relation to new ICMJE requirements around sharing data from clinical trials In January 2016, member journals of the...
View ArticleReport from the 2018 APHA meeting, Part 1: Research on Racial Disparities in...
In part one of a two-part series from the 2018 meeting of the American Public Health Association, PLOS Medicine Chief Editor Larry Peiperl discusses new evidence presented on racial disparities in...
View ArticleReport from the 2018 APHA Meeting, Part 2: Approaches to Reducing Gun Violence
In part two of a two-part series from the 2018 meeting of the American Public Health Association, PLOS Medicine Chief Editor Larry Peiperl reports from sessions that discussed strategies for reducing...
View Article